Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/404"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1520"
?:Evidence_type	?:Non_Tracable_Statement
?:Evidence_enzyme_system	""
dc:creator	"boycer"
dc:date	"05/21/2007 15:31:44"
?:content	"The FDA lists this as a recommended in vivo substrate of CYP3A4 in it most recent guidance document. See Appendix A, Table 2, p. 19"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ triazolam_primary_total_clearance_enzyme_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1520 }

Context graph